ARDX

NASD Ardelyx, Inc.
Oct 2, 2026 · 12:40 PM ET DELAYED Market Open

$3.30 ↓ -0.09 (-2.51%) Trading Down from the previous close of $3.38, $0.11 below the day’s high of $3.40

YTD change
-43.48%
vs 20-day SMA
-6.45%
vs 200-day SMA
-41.68%

Price ranges

Previous day
$3.36 $3.46
open $3.46 close $3.38
-$0.08 (-2.31%)
Today
$3.29 $3.40
open $3.38 now $3.30
-$0.09 (-2.51%)
Past week
$3.31 $3.49
from $3.45 now $3.30
-$0.16 (-4.49%)
Past month
$3.31 $3.92
from $3.80 now $3.30
-$0.51 (-13.29%)
This year
$3.29 $8.40
from $5.83 now $3.30
-$2.54 (-43.48%)

Price & Performance

-2.56 (-43.10%) / 6M

$3.07$4.58$6.10$7.61Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 79.8% away from all-time highs of $16.30
  • ARDX is down 43% since the beginning of the year
  • ARDX is down 37% over the past 12 months
  • ARDX is down 13% over the past 1 month
  • 10% of all ARDX investors are betting against ARDX

ARDX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -35.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.07
Earnings momentum -403.7% Quarterly EPS growth
Quarterly change -403.7%

Valuation

P/E ratio N/A
Enterprise value $812.8M
Beta 1.04

Balance sheet & scale

IncomeN/A
Revenue$450.9M
Cash$281.8M
Debt$256.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $821.1M

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $734.81 -3.09%
IQV IQVIA Holdings Inc $260.72 -3.02%
CRL Charles River Laboratories International, Inc. $286.83 -2.77%
ICLR ICON Plc $161.85 -4.79%
IT Gartner, Inc. $192.80 +3.36%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.